Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Liver Transplantation Status in Iran: A Multi-Center Report on the Main Transplant Indicators and Survival Rates Pubmed



Malekhosseini SA1 ; Jafarian A2 ; Nikeghbalian S1 ; Poustchi H3 ; Lankarani KB1 ; Toosi MN2 ; Salahi H1 ; Dehghani SM1 ; Eshraghian A1 ; Sharafkhah M3 ; Eghtesad S3 ; Motamedgorji N3 ; Kazemi K1 ; Salimi J2 Show All Authors
Authors
  1. Malekhosseini SA1
  2. Jafarian A2
  3. Nikeghbalian S1
  4. Poustchi H3
  5. Lankarani KB1
  6. Toosi MN2
  7. Salahi H1
  8. Dehghani SM1
  9. Eshraghian A1
  10. Sharafkhah M3
  11. Eghtesad S3
  12. Motamedgorji N3
  13. Kazemi K1
  14. Salimi J2
  15. Moini M2
  16. Shamsaeefar A1
  17. Moini M2
  18. Dehghani M4
  19. Khosravi MB1
  20. Najafi A2
  21. Sattari H4
  22. Geramizadeh B1
  23. Shafiee M4
  24. Toutouni MN5
  25. Sanei B6
  26. Nejatollahi SM7
  27. Taghavi A1
  28. Bahador A1
  29. Aliakbarian M5
  30. Eghtesad B8
  31. Malekzadeh R3
Show Affiliations
Authors Affiliations
  1. 1. Shiraz Transplant Center, Nemazee Hospital, Shiraz University of Medical Sciences, Shiraz, Iran
  2. 2. Liver Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Afzalipour Hospital, Kerman University of Medical Sciences, Kerman, Iran
  5. 5. Department of Surgery, Mashhad University of Medical Sciences, Mashhad, Iran
  6. 6. Isfahan University of Medical Sciences, Isfahan, Iran
  7. 7. The Division of Hepatobiliary and Organ Transplantation, Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  8. 8. Cleveland Clinic, Cleveland, OH, United States

Source: Archives of Iranian Medicine Published:2018


Abstract

Background: Iran’s experience with liver transplantation (LT) began more than two decades ago. The purpose of this article is to present the status of LT in Iran, review specific characteristics of the programs, their outcomes, and their growth to become one of the largest LT programs in the world. Methods: A questionnaire, asking for data on the number of transplants performed and specifics of the recipients and type of donors with focus on indications and outcomes was sent to LT programs. Results: During a period of 23 years, 4,485 LTs were performed at 6 centers in the country. Of these, 4106 were from deceased donors and 379 were from living donors. There were 3553 adults and 932 pediatric recipients. Hepatitis B and biliary atresia were the most common etiologies in adult and pediatric patients, respectively. Overall survival rates at 1, 5, and 10 years were 85%, 77%, and 71% for adults and 76%, 67% and 56% for pediatric patients, respectively. Conclusion: Approval of the brain death law in Iran and coordinated efforts by the transplant centers to build comprehensive LT programs has resulted in the ability to procure more than 700 deceased donors per year with acceptable long-term survival. © 2018 The Author(s).